Healthcare
|
janderson@mosessinger.com
T: (212) 554-7836 F: (917) 206-4377 Jill E. Anderson is counsel to the Healthcare practice. Ms. Anderson has extensive experience in healthcare transactions and counsels biotechnology and pharmaceutical companies, academic medical centers, teaching hospitals and research foundations on regulatory and compliance issues, with an emphasis on translational and clinical research.
Ms. Anderson has significant experience drafting and negotiating transactional agreements and identifying regulatory and compliance risks. She counsels in matters related to clinical trials, HIPAA and privacy, research protocols, patient informed consents, research grants, tissue repositories, Medicare reimbursement, research misconduct, fraud and abuse issues, anti-kickback laws and clinical trial disclosure and registration requirements. Ms. Anderson also assists clients in developing and implementing policies, guidelines and compliance strategies and in training staff on compliance issues. She regularly acts for a scientific research consortium in transactional matters pertaining to translational research.
Ms. Anderson was formerly an attorney with two Harvard-affiliated academic medical centers, where she focused on regulatory and compliance issues related to clinical research. She began her career as an attorney with Hale and Dorr (now WilmerHale) in Boston.
EDUCATION
- Widener University School of Law, J.D., 1999
- Rutgers University, B.S., 1996
LAW SCHOOL ACTIVITIES/HONORS
- Widener Law Symposium Journal
- Member, Phi Delta Phi
ARTICLES
- "Healthcare Reform Law May Impact Clinical Trial Billing and Contract Negotiations," Moses & Singer Client Alert, May 2010.
- "New Rules for Investigational Drugs Effective October 13, 2009," Moses & Singer Client Alert, August 2009.
- "The Children's Health Insurance Program Reauthorization Act of 2009," Moses & Singer Client Alert, February 2009.
- "GINA May Affect Informed Consent Forms," Moses & Singer Client Alert, June 2008.
- "Sponsors Beware: FDAAA Creates Compliance Challenges for Drug and Medical Device Clinical Trials," Bloomberg Law Reports®: Health Law, March 2008.
- "The Consolidated Appropriations Act, 2008," Moses & Singer Client Alert, January 2008.
- "Ownership of Biological Materials," American Health Lawyers Association, December 2007.
- "The Food and Drug Administration Amendments Act of 2007," Moses & Singer Client Alert, October 2007.
- "Senators to Reintroduce Legislation in Wake of Abigail Decision," interview, Bioresearch Compliance Report, August 2007.
- "Privacy and Security Bulletin," Moses & Singer Newsletter, May 2006.
PROFESSIONAL AFFILIATIONS
- American Health Lawyers Association, Life Sciences and Academic Medical Centers/Teaching Hospitals Practice Groups
- Boston Bar Association, Health Law Section
- Women Entrepreneurs in Science and Technology
- Harvard Biotechnology Club
BAR/COURT ADMISSIONS
- Massachusetts, 2001
- New York, 2008
PRESENTATIONS
- New England Healthcare Internal Auditors Association, Clinical Trials and Research Compliance, May 2008
- Massachusetts General Hospital Institute of Health Professions, Graduate Program in Clinical Investigations, Guest Lecturer, Law and Health Policy in Clinical Research, November 2007
- Healthcare Financial Management Association, Regulatory Issues in Clinical Research, November 2007
|